Moreover, CRC patients with a high CSC signature represented by the CSC specific genes (NOTUM, SMOC2, BAMBI, PHLDA1, TNFRSF19, PROX1, IFI27, and ERBB3), exhibited significantly worse survival (Figure S6b left, Supporting Information). This evidence concerns the gene PROX1 and colorectal carcinoma.